Tiamenidine

DB19607ExperimentalSmall molecule

Tiamenidine is a small molecule drug. The usage of the INN stem '-nidine' in the name indicates that Tiamenidine is a a2 adrenoreceptor agonist. Tiamenidine has a monoisotopic molecular weight...

Mechanism: Pharmacologically active on Alpha-2 adrenergic receptors
Curator reviewed
Formula / weight: C₈H₁₀ClN₃S · 215.7 g/mol (avg)
Code names: HOE-440

Resolves to

Compound

UNII195V08O55GCAS31428-61-2ChEMBLCHEMBL295409ChEBI134896

Structure

InChIKeyCVWILQHZFWRYPB-UHFFFAOYSA-NSMILESCC1=CSC(Cl)=C1NC1=NCCN1

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Tiamenidine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account